Approval · Notice of Compliance 13194 · 2012
DOLPAC 2: Notice of Compliance 13194
Issued April 10, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13194
- Date
- April 10, 2012
- Company
- Vetoquinol N A IncLavaltrie, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New Indication
- Therapeutic class
- Antihelmintic
Products in this notice
Medicinal ingredients
- OXANTEL PAMOATE 111.8 MG per TAB
- PRAZIQUANTEL 10 MG per TAB
- PYRANTEL PAMOATE 28.8 MG per TAB
- OXANTEL PAMOATE 559 MG per TAB
- PRAZIQUANTEL 50 MG per TAB
- PYRANTEL PAMOATE 144 MG per TAB
- OXANTEL PAMOATE 1,397.5 MG per TAB
- PRAZIQUANTEL 125 MG per TAB
- PYRANTEL PAMOATE 360 MG per TAB